These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10175551)

  • 21. Cost-effectiveness analysis of a dry powder inhaler (Turbuhaler) versus a pressurised metered dose inhaler in patients with asthma.
    Liljas B; Stådhl E; Pauwels RA
    Pharmacoeconomics; 1997 Aug; 12(2 Pt 2):267-77. PubMed ID: 10170451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Could interchangeable use of dry powder inhalers affect patients?
    Price D; Summers M; Zanen P
    Int J Clin Pract Suppl; 2005 Dec; (149):3-6. PubMed ID: 16279996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamic study of procaterol hydrochloride dry powder inhaler: evaluation of pharmacodynamic equivalence between procaterol hydrochloride dry powder inhaler and procaterol hydrochloride metered-dose inhaler in asthma patients in a randomized, double-dummy, double-blind crossover manner.
    Kawai M; Sakai A; Takaori S; Hiura A; Sakata N; Nakashima M; Miyamoto T
    Methods Find Exp Clin Pharmacol; 2005; 27(6):385-9. PubMed ID: 16179955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient satisfaction with budesonide Turbuhaler versus triamcinolone acetonide administered via pressurized metered-dose inhaler in a managed care setting.
    Weiss KB; Paramore LC; Liljas B; Revicki DA; Luce BR
    J Asthma; 2005 Nov; 42(9):769-76. PubMed ID: 16316872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of compliance in children using inhaled beta adrenergic agonists.
    Zora JA; Lutz CN; Tinkelman DG
    Ann Allergy; 1989 May; 62(5):406-9. PubMed ID: 2566291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma.
    Stempel DA; Riedel AA; Carranza Rosenzweig JR
    Curr Med Res Opin; 2006 Mar; 22(3):463-70. PubMed ID: 16574030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDI for acute asthma in children.
    Slawson JG; Flynn CA
    J Fam Pract; 1998 Jan; 46(1):18-9. PubMed ID: 9451362
    [No Abstract]   [Full Text] [Related]  

  • 28. [Beta 2 adrenergic and synthetic atropine drugs as inhalants in asthma in children].
    Delacourt C; de Blic J; Le Bourgeois M; Scheinmann P; Paupe J
    Pediatrie; 1989; 44(7):545-50. PubMed ID: 2573035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the everyday use of a metered dose aerosol triggered by inhalation (the "Autohaler" system)].
    Le Cocguic Y; Zureik M
    Rev Pneumol Clin; 1997; 53(1):13-9. PubMed ID: 9181147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Missed opportunities to transition from nebulizers to inhalers during hospitalization for acute asthma: A multicenter observational study.
    Press VG; Hasegawa K; Heidt J; Bittner JC; Camargo CA
    J Asthma; 2017 Nov; 54(9):968-976. PubMed ID: 28095080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cost effectiveness of BDP/formoterol fixed vs. two single inhalers in the treatment of bronchial asthma].
    Kardos P; Brüggenjürgen B; Ezzat N; Buhl R
    MMW Fortschr Med; 2010 Oct; 152 Suppl 3():102-5. PubMed ID: 21595154
    [No Abstract]   [Full Text] [Related]  

  • 32. Metered-dose inhalers and nebulizers in the acute setting.
    Kisch GL; Paloucek FP
    Ann Pharmacother; 1992 Jan; 26(1):92-5. PubMed ID: 1351411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost comparison of beta 2-agonist bronchodilators used in the treatment of asthma.
    Nightingale CH
    Pharmacotherapy; 1995; 15(5):677-81. PubMed ID: 8570443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Misuse of pressurized metered dose inhalers by asthmatic patients treated in French private practice.
    Liard R; Zureik M; Aubier M; Korobaeff M; Henry C; Neukirch F
    Rev Epidemiol Sante Publique; 1995; 43(3):242-9. PubMed ID: 7784673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical assessment of a new breath-actuated inhaler.
    Crompton G; Duncan J
    Practitioner; 1989 Feb; 233(1463):268-9. PubMed ID: 2587490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics of asthmatic patients prescribed various beta-agonist metered-dose inhalers at Yamagata University Hospital.
    Ojima F; Nakamura H; Ebihara M; Shoji T; Tomike H; Nakagawa Y
    Yakugaku Zasshi; 2001 Jan; 121(1):79-84. PubMed ID: 11201164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between short-acting β2-adrenergic agonist use and healthcare costs.
    Silver HS; Blanchette CM; Kamble S; Petersen H; Letter MA; Meddis D; Gutierrez B
    Am J Manag Care; 2011 Jan; 17(1):19-27. PubMed ID: 21348565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incorrect use of metered dose inhaler by pediatric residents.
    Benjaponpitak S; Kraisarin C; Direkwattanachai C; Sasisakunporn C
    J Med Assoc Thai; 1996 Feb; 79(2):122-6. PubMed ID: 8868024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhaled bronchodilators during mechanical ventilation: delivery techniques, evaluation of response, and cost-effectiveness.
    Hess D
    Respir Care; 1994 Feb; 39(2):105-22. PubMed ID: 10145961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective study of bitolterol mesylate in the treatment of conditions associated with reversible bronchospasm.
    Messina MS
    Adv Ther; 1995; 12(3):157-63. PubMed ID: 10155050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.